Bibracher C
Fortschr Med. 1979 Jan 11;97(2):78-80.
A double blind trial is described in which the effect of the specific gastric secretion inhibitor, Gastrozepin, was tested on gastric disturbances during treatment with the antirheumatic drug indometacin. It was shown on further treatment with indometacin and concomitant Gastrozepin therapy that the symptoms could be improved or completely relieved.